Metropolis Healthcare IPO

Metropolis Healthcare IPOMetropolis Healthcare IPO description - Metropolis Healthcare is one of the leading diagnostics companies in India, by revenue, as of March 31, 2018 (Source: Frost & Sullivan). The company has widespread presence across 18 states in India, with leadership position in west and south India. Through its widespread operational network, Metropolis Healthcare offers a comprehensive range of clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease. The company also offers analytical and support services to clinical research organizations for their clinical research projects. During the financial year 2018, it conducted approximately 16.0 million tests from approximately 7.7 million patient visits.

The company offers a broad range of approximately 3,480 clinical laboratory tests and 524 profiles. The profile comprises of a variety of test combinations which are specific to a disease or disorder as well as wellness profiles that are used for health and fitness screening. Its tests are classified in three categories - (i) ‘routine’ tests such as blood chemistry analyses, blood cell counts and urine examination; (ii) ‘semi-specialized’ tests such as thyroid function tests, viral and bacterial cultures, histology, cytology and infectious disease tests; and (iii) ‘specialized’ tests such as tests for coagulation studies, autoimmunity tests, cytogenetics and molecular diagnostics.

Promoters of Metropolis Healthcare - Dr Sushil Kanubhai Shah, Ameera Sushil Shah and Metz Advisory LLP
Metropolis Healthcare IPO details
Subscription Dates 3 - 5 April 2019
Price Band INR877 - 880 per share
Fresh issue Nil
Offer For Sale 13,685,095 shares (INR1,200.2 - 1,204.29 crore)
Total IPO size 13,685,095 shares (INR1,200.2 - 1,204.29 crore)
Minimum bid (lot size) 17 shares
Face Value  INR2 per share
Retail Allocation 10%
Listing On NSE, BSE
Metropolis Healthcare's financial performance (in INR crore)
FY2016 FY2017 FY2018 9M FY2019
Total revenues 490.6 567.7 651.6 566.8
Total expenses 366.4 410.4 491.3 431.2
Comprehensive income 80.0 107.5 110.5 90.6
Net margin (%) 16.3 18.9 17.0 16.0
Metropolis Healthcare Contact Details

Metropolis Healthcare Limited 
250 D Udyog Bhavan, Hind Cycle Marg,
Worli, Mumbai 400 030

Phone: +91 22 6258 2810
Email: [email protected]
Website: www.metropolisindia.com

Registrar of Metropolis IPO

Link Intime India Private Limited
C-101, 1st Floor, 247 Park
Lal Bahadur Shastri Marg, Vikhroli (West)
Mumbai - 400 083

Phone: +91 22 4918 6200
Fax: +91 22 4918 6195
Email[email protected]
Website: http://www.linkintime.co.in

Valuation of Metropolis Healthcare (FY2018)

Earnings Per Share (EPS): INR20.49

Price/Earnings (PE ratio): 42.80-42.95

Return on Net Worth (RONW): 24.66%

Net Asset Value (NAV): INR83.58 per share

Metropolis Healthcare IPO Subscription Details
Category Shares offered Subscription (no. of times)
Day 1 Day 2 Day 3
QIB 4,015,529 0.09 0.64 9.07
NII 2,007,764 0.00 0.01 3.03
Retail 1,338,509 0.25 0.69 2.03
Employees 300,000 0.00 0.01 0.05
Total 7,661,802 0.09 0.46 5.80
Metropolis Healthcare IPO Allotment Status

Metropolis Healthcare IPO allotment status is now available on Link Intime's website. Click on this link to get allotment status.

Listing Performance of Metropolis Healthcare Limited

IPO Opening Date: 3 April 2019

IPO Closing Date: 5 April 2019

Finalisation of Basis of Allotment: 10 April 2019

Initiation of refunds: 11 April 2019

Transfer of shares to demat accounts: 12 April 2019

Listing Date: 15 April 2019

Listing Price on NSE: INR958 per share (up 8.86% from IPO price)

Closing Price on NSE: INR959.85 per share (up 9.07% from IPO price)

Metropolis Healthcare IPO
4.2 (83.08%) 26 vote[s]

2 thoughts on “Metropolis Healthcare IPO

  • March 28, 2019 at 2:30 PM
    Permalink

    Good company ipo after a long time

    Reply
    • April 2, 2019 at 8:35 AM
      Permalink

      How is it good? I think it is expensive when compared to its competitors like Thyrocare.

      Reply

Leave a Reply

Your email address will not be published. Required fields are marked *